354 related articles for article (PubMed ID: 17001158)
1. Hyalinizing trabecular adenoma of the thyroid revisited: a histologic and immunohistochemical study of thyroid lesions with prominent trabecular architecture and sclerosis.
Galgano MT; Mills SE; Stelow EB
Am J Surg Pathol; 2006 Oct; 30(10):1269-73. PubMed ID: 17001158
[TBL] [Abstract][Full Text] [Related]
2. Hyalinizing trabecular adenoma of the thyroid gland.
Bishop JA; Ali SZ
Diagn Cytopathol; 2011 Apr; 39(4):306-10. PubMed ID: 20730896
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic usefulness of HBME1, galectin-3, CK19, and CITED1 and evaluation of their expression in encapsulated lesions with questionable features of papillary thyroid carcinoma.
Scognamiglio T; Hyjek E; Kao J; Chen YT
Am J Clin Pathol; 2006 Nov; 126(5):700-8. PubMed ID: 17050067
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy.
de Matos PS; Ferreira AP; de Oliveira Facuri F; Assumpção LV; Metze K; Ward LS
Histopathology; 2005 Oct; 47(4):391-401. PubMed ID: 16178894
[TBL] [Abstract][Full Text] [Related]
5. Hyalinizing trabecular adenoma--an uncommon thyroid tumor frequently misdiagnosed as papillary or medullary thyroid carcinoma.
Evenson A; Mowschenson P; Wang H; Connolly J; Mendrinos S; Parangi S; Hasselgren PO
Am J Surg; 2007 Jun; 193(6):707-12. PubMed ID: 17512281
[TBL] [Abstract][Full Text] [Related]
6. [Hyalinizing trabecular adenoma of the thyroid].
Hardisson Hernáez D; Prim Espada MP; De Diego Sastre JI; Nistal Martín de Serrano M
Acta Otorrinolaringol Esp; 1999 Apr; 50(3):243-6. PubMed ID: 10362873
[TBL] [Abstract][Full Text] [Related]
7. Fine-needle aspiration biopsy of papillary thyroid carcinoma: diagnostic utility of cytokeratin 19 immunostaining.
Nasser SM; Pitman MB; Pilch BZ; Faquin WC
Cancer; 2000 Oct; 90(5):307-11. PubMed ID: 11038428
[TBL] [Abstract][Full Text] [Related]
8. Hyalinizing trabecular adenoma of the thyroid gland--a report of two cases.
Lewy-Trenda I; Wierzchniewska-Lawska A
Pol J Pathol; 1999; 50(4):301-3. PubMed ID: 10721271
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor gamma expression in follicular-patterned thyroid lesions. Caveats for the use of immunohistochemical studies.
Gustafson KS; LiVolsi VA; Furth EE; Pasha TL; Putt ME; Baloch ZW
Am J Clin Pathol; 2003 Aug; 120(2):175-81. PubMed ID: 12931546
[TBL] [Abstract][Full Text] [Related]
10. Hyalinizing trabecular adenoma of the thyroid--morphology and differential diagnosis.
Schmid KW; Mesewinkel F; Böcker W
Acta Med Austriaca; 1996; 23(1-2):65-8. PubMed ID: 8767518
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of follicular variant of papillary thyroid carcinoma in fine-needle aspirates processed by ultrafast Papanicolaou stain: histologic follow-up of 125 cases.
Yang GC; Liebeskind D; Messina AV
Cancer; 2006 Jun; 108(3):174-9. PubMed ID: 16541452
[TBL] [Abstract][Full Text] [Related]
12. Cribriform-morular variant of papillary carcinoma: a distinctive variant representing the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma?
Cameselle-Teijeiro J; Chan JK
Mod Pathol; 1999 Apr; 12(4):400-11. PubMed ID: 10229505
[TBL] [Abstract][Full Text] [Related]
13. Follicular neoplasm of the thyroid--vanishing cytologic diagnosis?
Kapur U; Wojcik EM
Diagn Cytopathol; 2007 Aug; 35(8):525-8. PubMed ID: 17636488
[TBL] [Abstract][Full Text] [Related]
14. Hyalinizing trabecular adenoma--a case report with FNAC histologic, MIB-1 proliferative index and immunohistochemical findings.
Karak AK; Sahoo M; Bhatnagar D
Indian J Pathol Microbiol; 1998 Oct; 41(4):479-84. PubMed ID: 9866913
[TBL] [Abstract][Full Text] [Related]
15. [Hyalinizing trabecular adenoma of the thyroid gland. Histologic and immunohistochemical study. Report of 2 cases].
Fornes P; Lesourd A; Dupuis G; Merceron RE; Sarfati E; Guettier C; Brocheriou C
Arch Anat Cytol Pathol; 1990; 38(5-6):203-7. PubMed ID: 2281955
[TBL] [Abstract][Full Text] [Related]
16. HBME1 and CK19 expression in non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) vs other follicular patterned thyroid lesions.
Sadiq Q; Sekhri R; Dibaba DT; Zhao Q; Agarwal S
World J Surg Oncol; 2021 May; 19(1):143. PubMed ID: 33964951
[TBL] [Abstract][Full Text] [Related]
17. Encapsulated papillary oncocytic neoplasms of the thyroid: morphologic, immunohistochemical, and molecular analysis of 18 cases.
Woodford RL; Nikiforov YE; Hunt JL; Bellizzi AM; Zhang X; Mills SE; Stelow EB
Am J Surg Pathol; 2010 Nov; 34(11):1582-90. PubMed ID: 20924280
[TBL] [Abstract][Full Text] [Related]
18. [Expression of cytokeratin19, galectin-3 and HBME-1 in thyroid lesions and their differential diagnoses].
Teng XD; Wang LJ; Yao HT; Li J; Ding W; Yan LP
Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):212-6. PubMed ID: 15256110
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical diagnosis of papillary thyroid carcinoma.
Cheung CC; Ezzat S; Freeman JL; Rosen IB; Asa SL
Mod Pathol; 2001 Apr; 14(4):338-42. PubMed ID: 11301350
[TBL] [Abstract][Full Text] [Related]
20. Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma.
Elsheikh TM; Asa SL; Chan JK; DeLellis RA; Heffess CS; LiVolsi VA; Wenig BM
Am J Clin Pathol; 2008 Nov; 130(5):736-44. PubMed ID: 18854266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
